216 related articles for article (PubMed ID: 14668571)
1. In vitro effects of clopidogrel on the platelet-subendothelium interaction, platelet thromboxane and endothelial prostacyclin production, and nitric oxide synthesis.
Arrebola MM; De la Cruz JP; Villalobos MA; Pinacho A; Guerrero A; Sánchez de la Cuesta F
J Cardiovasc Pharmacol; 2004 Jan; 43(1):74-82. PubMed ID: 14668571
[TBL] [Abstract][Full Text] [Related]
2. Influence of glucose concentration on the effects of aspirin, ticlopidine and clopidogrel on platelet function and platelet-subendothelium interaction.
De La Cruz JP; Arrebola MM; Villalobos MA; Pinacho A; Guerrero A; González-Correa JA; Sánchez de la Cuesta F
Eur J Pharmacol; 2004 Jan; 484(1):19-27. PubMed ID: 14729378
[TBL] [Abstract][Full Text] [Related]
3. Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats.
De La Cruz P; Arrebola M; González-Correa A; Martinez-Cerdán E; Moreno A; de la Cuesta FS
Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):204-10. PubMed ID: 12595963
[TBL] [Abstract][Full Text] [Related]
4. Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood.
González-Correa JA; Arrebola MM; Guerrero A; Muñoz-Marín J; Ruiz-Villafranca D; Sánchez de La Cuesta F; De La Cruz JP
Platelets; 2005; 16(3-4):171-9. PubMed ID: 16011961
[TBL] [Abstract][Full Text] [Related]
5. Effects of clopidogrel and aspirin on platelet aggregation, thromboxane production, and serotonin secretion in horses.
Brainard BM; Epstein KL; LoBato D; Kwon S; Papich MG; Moore JN
J Vet Intern Med; 2011; 25(1):116-22. PubMed ID: 21143302
[TBL] [Abstract][Full Text] [Related]
6. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.
de la Cruz JP; Guerrero A; González-Correa JA; Márquez E; Nacle I; Sánchez de la Cuesta F
Eur J Clin Pharmacol; 2002 Jan; 57(11):775-80. PubMed ID: 11871383
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation.
Rollini F; Tello-Montoliu A; Patel R; Darlington A; Wilson RE; Franchi F; Muñiz-Lozano A; Desai B; Bender N; Sakariassen KS; Angiolillo DJ
J Thromb Thrombolysis; 2014; 37(2):131-8. PubMed ID: 23943337
[TBL] [Abstract][Full Text] [Related]
8. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
De La Cruz JP; Villalobos MA; Escalante R; Guerrero A; Arrebola MM; Sánchez de La Cuesta F
Br J Pharmacol; 2002 Dec; 137(7):1082-8. PubMed ID: 12429581
[TBL] [Abstract][Full Text] [Related]
9. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.
Eikelboom JW; Hankey GJ; Thom J; Claxton A; Yi Q; Gilmore G; Staton J; Barden A; Norman PE
J Thromb Haemost; 2005 Dec; 3(12):2649-55. PubMed ID: 16359503
[TBL] [Abstract][Full Text] [Related]
11. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension.
Robbins IM; Kawut SM; Yung D; Reilly MP; Lloyd W; Cunningham G; Loscalzo J; Kimmel SE; Christman BW; Barst RJ
Eur Respir J; 2006 Mar; 27(3):578-84. PubMed ID: 16507859
[TBL] [Abstract][Full Text] [Related]
12. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
Dallob A; Luo WL; Luk JM; Ratcliffe L; Johnson-Levonas AO; Schwartz JI; Dishy V; Kraft WK; De Hoon JN; Van Hecken A; De Lepeleire I; Radziszewski W; Wagner JA; Lai E
Platelets; 2011; 22(7):495-503. PubMed ID: 21526889
[TBL] [Abstract][Full Text] [Related]
13. Response to aspirin and clopidogrel monitored with different platelet function methods.
Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
[TBL] [Abstract][Full Text] [Related]
14. Reversal of the anti-platelet effects of aspirin and clopidogrel.
Li C; Hirsh J; Xie C; Johnston MA; Eikelboom JW
J Thromb Haemost; 2012 Apr; 10(4):521-8. PubMed ID: 22268852
[TBL] [Abstract][Full Text] [Related]
15. Dynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy.
Tsoumani ME; Tatsidou PT; Ntalas IV; Goudevenos JA; Tselepis AD
Platelets; 2016 Dec; 27(8):812-820. PubMed ID: 27337147
[TBL] [Abstract][Full Text] [Related]
16. Effects of clopidogrel on "aspirin specific" pathways of platelet inhibition.
Hobson AR; Qureshi Z; Banks P; Curzen NP
Platelets; 2009 Sep; 20(6):386-90. PubMed ID: 19811222
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the activation of thienopyridines by cytochromes P450 using a pharmacodynamic assay in vitro.
Abell LM; Liu EC
J Pharmacol Exp Ther; 2011 Nov; 339(2):589-96. PubMed ID: 21828263
[TBL] [Abstract][Full Text] [Related]
18. Reduction of platelet thromboxane A2 production ex vivo and in vivo by clopidogrel therapy.
Armstrong PC; Dhanji AR; Tucker AT; Mitchell JA; Warner TD
J Thromb Haemost; 2010 Mar; 8(3):613-5. PubMed ID: 19995405
[No Abstract] [Full Text] [Related]
19. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography Platelet Mapping.
Collyer TC; Gray DJ; Sandhu R; Berridge J; Lyons G
Br J Anaesth; 2009 Apr; 102(4):492-8. PubMed ID: 19286767
[TBL] [Abstract][Full Text] [Related]
20. Determination of aspirin responsiveness by use of whole blood platelet aggregometry.
Ivandic BT; Giannitsis E; Schlick P; Staritz P; Katus HA; Hohlfeld T
Clin Chem; 2007 Apr; 53(4):614-9. PubMed ID: 17332149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
